Key result
Ion channel auxiliary subunits are increasingly linked to cancer, functioning as oncogenes or tumor suppressors, and represent potential biomarkers and therapeutic targets.
Why the study?
Further mechanistic understanding is required into how ion channel auxiliary subunits contribute to tumour progression before their potential as biomarkers and therapeutic targets can be fully realised.
Ion channel auxiliary subunits play significant roles in cancer progression and may serve as potential biomarkers and therapeutic targets.
May nominate auxiliary subunits as oncology biomarkers or targets; leaves open clinical utility pending prospective trials.
Several superfamilies of plasma membrane channels which regulate transmembrane ion flux have also been shown to regulate a multitude of cellular processes, including proliferation and migration. Ion channels are typically multimeric complexes consisting of conducting subunits and auxiliary, non-conducting subunits. Auxiliary subunits modulate the function of conducting subunits and have putative non-conducting roles, further expanding the repertoire of cellular processes governed by ion channel complexes to processes such as transcellular adhesion and gene transcription. Given this expansive influence of ion channels on cellular behaviour it is perhaps no surprise that aberrant ion channel expression is a common occurrence in cancer. This review will focus on the conducting and non-conducting roles of the auxiliary subunits of various Ca2+, K+, Na+ and Cl− channels and the burgeoning evidence linking such auxiliary subunits to cancer. Several subunits are upregulated (e.g. Cavβ, Cavγ) and downregulated (e.g. Kvβ) in cancer, while other subunits have been functionally implicated as oncogenes (e.g. Navβ1, Cavα2δ1) and tumour suppressor genes (e.g. CLCA2, KCNE2, BKγ1) based on in vivo studies. The strengthening link between ion channel auxiliary subunits and cancer has exposed these subunits as potential biomarkers and therapeutic targets. However further mechanistic understanding is required into how these subunits contribute to tumour progression before their therapeutic potential can be fully realised.
No takes yet. Share an insight, caveat, or question.
Haworth et al. (2019) conducted a review in Cancer. Ion channel auxiliary subunits was evaluated. Ion channel auxiliary subunits are increasingly linked to cancer, functioning as oncogenes or tumor suppressors, and represent potential biomarkers and therapeutic targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: